Strumento inattivo

Azioni Chelsea Therapeutics International Ltd.

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson's Disease and Movement Disorders	12/06/14
Chelsea Therapeutics : Newman Ferrara LLP : Announces Investigation of Chelsea Therapeutics International Ltd.	09/05/14
Chelsea Therapeutics : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Chelsea Therapeutics International, Ltd. Stockholders	09/05/14
Wall Street finit sur une note mitigée, baisse du Nasdaq	08/05/14
Chelsea Therapeutics Joins NORD in Promoting Awareness for Rare Disease Day	28/02/14

Settore

	Variaz. 1 gen.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-1,17%	104 Mrd
REGENERON PHARMACEUTICALS, INC.	+2,87%	97,47 Mrd
ARGENX SE	+4,19%	22,25 Mrd
BIONTECH SE	-14,77%	21,68 Mrd
GENMAB A/S	-8,82%	18,2 Mrd
WUXI APPTEC CO., LTD.	-39,98%	17,02 Mrd
BEIGENE, LTD.	-13,21%	16,36 Mrd
NEUROCRINE BIOSCIENCES, INC.	+8,55%	14,39 Mrd
SAREPTA THERAPEUTICS, INC.	+35,75%	12,37 Mrd